Announcement under Regulation 30 relating to dilution in shareholding in Subsidiary company namely Peptech Biosciences Limited on right issue of partly paid up shares by Peptech Biosciences Limited and subscribing of lessor number of shares in the right issue resulting in dilution of shareholding in Peptech Biosciences Limited. The Peptech Biosciences Ltd status changed from subsidiary company to an associate company.

pdf

Titan Biotech Ltd.

10 Feb 2022

979.60

1.11%

Company Update

TITAN BIOTECH LTD. - 524717 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of unaudited financial results for quarter ended 31st December, 2021.

pdf

Titan Biotech Ltd.

09 Feb 2022

979.60

1.11%

Result

TITAN BIOTECH LTD. - 524717 - Unaudited Financial Results For Quarter Ended 31St December, 2021

BSE India

unaudited financial Results for quarter ended 31st December, 2021

pdf

Titan Biotech Ltd.

31 Jan 2022

979.60

1.11%

Board Meeting

TITAN BIOTECH LTD. - 524717 - Board Meeting Intimation for Considering Unaudited Quarterly Financial Results For …

BSE India

TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 ,inter alia, to consider and approve unaudited quarterly financial results for the quarter ended 31st December, 2021.

pdf

Is Titan Biotech Ltd. worth buying?

143 Votes:

Buy 77.62%

Sell 16.08%

Hold 6.29%